Stay updated on Pembrolizumab Combo in Gastro Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab Combo in Gastro Cancer Clinical Trial page.

Latest updates to the Pembrolizumab Combo in Gastro Cancer Clinical Trial page
- Check5 days agoChange DetectedThe page shows revision v3.5.0, replacing the previous revision v3.4.3.SummaryDifference0.1%

- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check27 days agoNo Change Detected
- Check41 days agoChange DetectedThe update adds a related topic 'Gastric cancer' and an external resource link to the Genetic and Rare Diseases Information Center, plus a page revision tag. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check49 days agoChange DetectedPage revision updated from v3.4.0 to v3.4.1, indicating a site version update. This update does not modify the study details, eligibility criteria, or outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check49 days agoChange DetectedRevision: v3.4.1 was added and v3.4.0 was removed.SummaryDifference0.1%

- Check57 days agoChange DetectedAdded: glossary toggle, Last Update Submitted that Met QC Criteria, No FEAR Act Data, and Revision: v3.4.0; removed: Last Update Submitted that met QC Criteria, No FEAR Act data, and Revision: v3.3.4.SummaryDifference0.2%

Stay in the know with updates to Pembrolizumab Combo in Gastro Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combo in Gastro Cancer Clinical Trial page.